United Therapeutics CEO Martine A. Rothblatt disposes of $4.3 million in common shares
UTHR•Martine A. Rothblatt exercised options for 9,500 United Therapeutics shares at $117.76 on Oct. 9, 2026. A family trust sold 9,099 shares at prices ranging from $531.92 to $550.7197, leaving it with 324,443 shares.
1. Share transactions
United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $117.76 on Oct. 9, 2026. A family trust sold 9,099 shares the same day at prices from $531.92 to $550.7197, and its common stock stake ended at 324,443 shares.
